Vagner E A, Davidov M I
Urol Nefrol (Mosk). 1998 Jan-Feb(1):23-7.
In massive blood loss (1000-4900 ml) during operations on the kidneys, urinary tract and prostate in 65 patients 750 to 3600 ml of blood were reinfused. Sixty (92.3%) patients recovered. Fatal outcomes in 5 cases were caused by complications of the underlying and concomitant diseases and were unrelated to blood reinfusion. Study of morphological, biochemical and coagulation properties of the patients' blood showed gradual restoration of hemostatic values and the absence of harmful effect of the reinfusion on the organism. The authors claim that blood reinfusion can be undertaken in operations on the kidney, urinary tract and prostate when there are vital indications. Kidney tumors are a relative contraindication for reinfusion. Blood reinfusion is not indicated in purulent diseases of the kidneys.
在65例接受肾脏、尿路和前列腺手术时发生大量失血(1000 - 4900毫升)的患者中,回输了750至3600毫升血液。60例(92.3%)患者康复。5例死亡结果是由基础疾病和伴随疾病的并发症引起的,与血液回输无关。对患者血液的形态学、生化和凝血特性研究表明,止血值逐渐恢复,且回输对机体无有害影响。作者声称,在有重要指征时,肾脏、尿路和前列腺手术中可进行血液回输。肾肿瘤是回输的相对禁忌证。肾脏化脓性疾病不适合进行血液回输。